Clinical Trials
17 trialsNCT06980792 2025-05-20
Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases
Azienda Ospedaliero-Universitaria di Modena
Completed
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT06461598 2024-06-17
Signature for Precise Chemosensitivity Prediction in PDAC
Ruijin Hospital
Completed
NCT01827553 2024-04-11
CONKO-007
University of Erlangen-Nürnberg Medical School
Phase 3 Completed
NCT03329950 2024-03-28
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Celldex Therapeutics
Phase 1 Completed
NCT04431258 2024-03-18
PanC-ASAP
Ability Pharmaceuticals SL
Phase 1/2 Completed
NCT00089024 2023-09-29
Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
University of Nebraska
Phase 2 Completed
NCT01470417 2023-08-22
GAIN-1
University of Florida
Phase 2 Completed
NCT03977272 2023-01-27
Combination of Anti-PD-1 Antibody and Chemotherapy in Metastatic Pancreatic Cancer
Zhejiang University
Phase 2 Completed
NCT03158779 2022-09-15
Evaluation of SBRT for Patients With Locally Advanced Unresectable Pancreatic Cancer
Istituto Clinico Humanitas
Phase 2 Completed
NCT02282722 2021-10-14
Improving Informed Consent for Palliative Chemotherapy
Dana-Farber Cancer Institute
Phase NA Completed
NCT00763516 2017-09-06
PC02
University of Florida
Phase NA Completed
NCT00685763 2017-08-24
PC01
University of Florida
Phase NA Completed
NCT02984501 2016-12-07
Study of Induction Chemotherapy Followed by Radiochemotherapy in Locally Advanced Pancreatic Cancer
Campus Bio-Medico University
Phase 2 Completed
NCT00785421 2015-01-08
PROSPECT
CONKO-Studiengruppe
Phase 2/3 Completed
NCT00711191 2013-12-24
A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The Pancreas
Hoffmann-La Roche
Phase 1 Completed
NCT00041808 2005-06-24
Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver
FeRx
Phase 1/2 Completed